pubmed-article:16190555 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16190555 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:16190555 | lifeskim:mentions | umls-concept:C0002199 | lld:lifeskim |
pubmed-article:16190555 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:16190555 | lifeskim:mentions | umls-concept:C0400914 | lld:lifeskim |
pubmed-article:16190555 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:16190555 | lifeskim:mentions | umls-concept:C0750729 | lld:lifeskim |
pubmed-article:16190555 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:16190555 | pubmed:dateCreated | 2005-9-29 | lld:pubmed |
pubmed-article:16190555 | pubmed:abstractText | The aim of the study was to estimate the course of acute hepatitis C and efficacy of 24 weeks monotherapy with interferon alpha 2b (IFN). | lld:pubmed |
pubmed-article:16190555 | pubmed:language | pol | lld:pubmed |
pubmed-article:16190555 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16190555 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16190555 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16190555 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16190555 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16190555 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16190555 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16190555 | pubmed:issn | 0033-2100 | lld:pubmed |
pubmed-article:16190555 | pubmed:author | pubmed-author:MachTomaszT | lld:pubmed |
pubmed-article:16190555 | pubmed:author | pubmed-author:Janas-Skulina... | lld:pubmed |
pubmed-article:16190555 | pubmed:author | pubmed-author:Zejc-Bajsarow... | lld:pubmed |
pubmed-article:16190555 | pubmed:author | pubmed-author:Cie?laAndrzej... | lld:pubmed |
pubmed-article:16190555 | pubmed:author | pubmed-author:WarunekWiolet... | lld:pubmed |
pubmed-article:16190555 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16190555 | pubmed:volume | 59 | lld:pubmed |
pubmed-article:16190555 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16190555 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16190555 | pubmed:pagination | 467-74 | lld:pubmed |
pubmed-article:16190555 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:meshHeading | pubmed-meshheading:16190555... | lld:pubmed |
pubmed-article:16190555 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16190555 | pubmed:articleTitle | [Clinical manifestations and effect of early therapy with interferon-alpha on the course of acute hepatitis C]. | lld:pubmed |
pubmed-article:16190555 | pubmed:affiliation | Klinika Chorób Zaka?nych i Hepatologii, Uniwersytet Jagiello?ski Collegium Medicum, Kraków. wioletaloranty@wp.pl | lld:pubmed |
pubmed-article:16190555 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16190555 | pubmed:publicationType | English Abstract | lld:pubmed |